What does COBRA APOTHEEK CENTRUM do?

COBRA APOTHEEK CENTRUM is a pharmacy in Mol. Private Limited, started on 29 December 1989, 1 establishment.

What is the address of COBRA APOTHEEK CENTRUM?

The registered office of COBRA APOTHEEK CENTRUM is located at Markt 23, 2400 Mol.

Is COBRA APOTHEEK CENTRUM still active?

Yes. According to the CBE (30 October 2026) COBRA APOTHEEK CENTRUM is active, legal situation “Normale toestand”, started on 29 December 1989.

Is COBRA APOTHEEK CENTRUM registered on Peppol?

Yes, COBRA APOTHEEK CENTRUM is registered on the Peppol network with ID 0208:0439260144.

What is the enterprise number of COBRA APOTHEEK CENTRUM?

The enterprise number of COBRA APOTHEEK CENTRUM is BE0439260144.

When was COBRA APOTHEEK CENTRUM founded?

COBRA APOTHEEK CENTRUM was founded on 29 December 1989.

Who are the directors of COBRA APOTHEEK CENTRUM?

According to the 2025 annual accounts, the directors of COBRA APOTHEEK CENTRUM are: FLYING PENGUIN BV.

Is COBRA APOTHEEK CENTRUM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 December 1989; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did COBRA APOTHEEK CENTRUM make in 2025?

COBRA APOTHEEK CENTRUM posted a profit after taxes of € 76,700 in financial year 2025.

What is the revenue of COBRA APOTHEEK CENTRUM?

As a small company, COBRA APOTHEEK CENTRUM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 332,315.

How much does an employee at COBRA APOTHEEK CENTRUM earn?

The average wage cost per full-time employee at COBRA APOTHEEK CENTRUM was € 76,800 in 2025: staff costs of € 199,553 for 2.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does COBRA APOTHEEK CENTRUM have?

According to the 2025 annual accounts, COBRA APOTHEEK CENTRUM has 2.6 full-time equivalents (FTE).

COBRA APOTHEEK CENTRUM (Private Limited) - Mol

Dossier COBRA APOTHEEK CENTRUM, printed on 30 October 2026 from databakkes.be/en/0439260144/cobra-apotheek-centrum. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 3.3 to 2.6.

Financials

Financial year 2025

COBRA APOTHEEK CENTRUM from Mol, company number BE0439260144, closed financial year 2025 with a result of € 76,700 after tax. For that financial year COBRA APOTHEEK CENTRUM recorded a gross margin of € 332,315 and equity of € 321,578. Compared with financial year 2024, the result moved from € 42,176 to € 76,700. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.

What it is worth Growing

€ 321,578

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 76,700

▲ 82% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 158,295

▲ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 35,000 paid out

46 % of the profit went to the shareholders, mostly to TYTGAT (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.6

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 199,553

▲ 2% vs 2024

€ 76,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,551

▲ 233% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 157,638

▼ 18% vs 2024

€ 18,365 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 221,900

▲ 33% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 28,748

▼ 11% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 266,784 Gross margin 2022: € 266,784 First fiscal year in the series	€ 334,673 Gross margin 2023: € 334,673 ▲ 25% vs 2022 (€ 266,784) Favourable step	€ 300,174 Gross margin 2024: € 300,174 ▼ 10% vs 2023 (€ 334,673) Unfavourable step	€ 332,315 Gross margin 2025: € 332,315 ▲ 11% vs 2024 (€ 300,174) Favourable step	▲ 11%
Profit after taxes	€ 47,993 Profit after taxes 2022: € 47,993 First fiscal year in the series	€ 76,355 Profit after taxes 2023: € 76,355 ▲ 59% vs 2022 (€ 47,993) Favourable step	€ 42,176 Profit after taxes 2024: € 42,176 ▼ 45% vs 2023 (€ 76,355) Unfavourable step	€ 76,700 Profit after taxes 2025: € 76,700 ▲ 82% vs 2024 (€ 42,176) Favourable step	▲ 82%
Equity	€ 211,347 Equity 2022: € 211,347 First fiscal year in the series	€ 287,702 Equity 2023: € 287,702 ▲ 36% vs 2022 (€ 211,347) Favourable step	€ 279,878 Equity 2024: € 279,878 ▼ 3% vs 2023 (€ 287,702) Unfavourable step	€ 321,578 Equity 2025: € 321,578 ▲ 15% vs 2024 (€ 279,878) Favourable step	▲ 15%
Total debts	€ 626,099 Total debts 2022: € 626,099 First fiscal year in the series	€ 428,963 Total debts 2023: € 428,963 ▼ 31% vs 2022 (€ 626,099) Favourable step	€ 442,467 Total debts 2024: € 442,467 ▲ 3% vs 2023 (€ 428,963) Unfavourable step	€ 469,698 Total debts 2025: € 469,698 ▲ 6% vs 2024 (€ 442,467) Unfavourable step	▲ 6%
Cash	€ 169,375 Cash 2022: € 169,375 First fiscal year in the series	€ 119,350 Cash 2023: € 119,350 ▼ 30% vs 2022 (€ 169,375) Unfavourable step	€ 137,663 Cash 2024: € 137,663 ▲ 15% vs 2023 (€ 119,350) Favourable step	€ 158,295 Cash 2025: € 158,295 ▲ 15% vs 2024 (€ 137,663) Favourable step	▲ 15%
Land & buildings	€ 172,837 Land & buildings 2022: € 172,837 First fiscal year in the series	€ 154,437 Land & buildings 2023: € 154,437 ▼ 11% vs 2022 (€ 172,837) Unchanged	€ 136,037 Land & buildings 2024: € 136,037 ▼ 12% vs 2023 (€ 154,437) Unchanged	€ 119,250 Land & buildings 2025: € 119,250 ▼ 12% vs 2024 (€ 136,037) Unchanged	▼ 12%
Retained profit	€ 42,797 Retained profit 2022: € 42,797 First fiscal year in the series	€ 119,152 Retained profit 2023: € 119,152 ▲ 178% vs 2022 (€ 42,797) Favourable step	€ 111,328 Retained profit 2024: € 111,328 ▼ 7% vs 2023 (€ 119,152) Unfavourable step	€ 153,028 Retained profit 2025: € 153,028 ▲ 37% vs 2024 (€ 111,328) Favourable step	▲ 37%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 50,000 Dividend 2024: € 50,000 Unchanged (€ 0) Unchanged	€ 35,000 Dividend 2025: € 35,000 ▼ 30% vs 2024 (€ 50,000) Unchanged	▼ 30%
Bank debt	€ 265,664 Bank debt 2022: € 265,664 First fiscal year in the series	€ 230,997 Bank debt 2023: € 230,997 ▼ 13% vs 2022 (€ 265,664) Favourable step	€ 193,334 Bank debt 2024: € 193,334 ▼ 16% vs 2023 (€ 230,997) Favourable step	€ 157,638 Bank debt 2025: € 157,638 ▼ 18% vs 2024 (€ 193,334) Favourable step	▼ 18%
Balance sheet total	€ 837,446 Balance sheet total 2022: € 837,446 First fiscal year in the series	€ 716,665 Balance sheet total 2023: € 716,665 ▼ 14% vs 2022 (€ 837,446) Unchanged	€ 722,345 Balance sheet total 2024: € 722,345 ▲ 1% vs 2023 (€ 716,665) Unchanged	€ 791,276 Balance sheet total 2025: € 791,276 ▲ 10% vs 2024 (€ 722,345) Unchanged	▲ 10%
Employees (FTE)	2.8 Employees (FTE) 2022: 2.8 First fiscal year in the series	3.3 Employees (FTE) 2023: 3.3 ▲ 0.5 vs 2022 (2.8) Unchanged	3.1 Employees (FTE) 2024: 3.1 ▼ 0.2 vs 2023 (3.3) Unchanged	2.6 Employees (FTE) 2025: 2.6 ▼ 0.5 vs 2024 (3.1) Unchanged	▼ 0.5

Key figures of COBRA APOTHEEK CENTRUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to COBRA APOTHEEK CENTRUM?

What happened at COBRA APOTHEEK CENTRUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 17, 2026 New annual accounts for financial year 2025: profit of € 76,700 (▲ 82% vs 2024). Source: NBB ↗
2024 FLYING PENGUIN BV became a director. NBB
Jan 12, 1990 New establishment in Mol. KBO
Dec 29, 1989 Start of the company according to the CBE. KBO

In short

From € 47,993 profit in 2022 to € 76,700 profit in 2025.

Paid € 72,755 in corporate taxes since 2022.

Best year ever: 2025, with € 76,700 profit.

On average € 127,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

FLYING PENGUIN

TYTGAT 100%

The stake of TYTGAT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

COBRA APOTHEEK CENTRUM

Behind COBRA APOTHEEK CENTRUM is FLYING PENGUIN BV. The shares are held by FLYING PENGUIN and TYTGAT (100%).

Directors

According to the 2025 annual accounts

FLYING PENGUIN BV

Director · represented by Nele De Munck

Also active at: APOTHEEK RAUW, Cobra Apotheek Dessel

since 2024

Shareholders

FLYING PENGUIN

TYTGAT

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Markt 23

2400 Mol

2.046.530.249

Statiestraat 51

2400 Mol

Active since 12 January 1990

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

COBRA APOTHEEK

€ 1 million gross margin · 2025

TYTGAT same network

€ 326,061 gross margin · 2025

Flying Penguin same network

€ 189,432 gross margin · 2025

Cobra Apotheek Rosselaar

€ 155,270 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0439.260.144

VAT number

BE 0439.260.144

Registered office

Markt 23, 2400 Mol

Names & denominations

COBRA APOTHEEK CENTRUM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 December 1989

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

COBRA APOTHEEK CENTRUM

Warning lights

Financials

What happened to COBRA APOTHEEK CENTRUM?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions